Scripps Research Institute Scientists Reveal Weak Spots in ZMapp's Defense Against Ebola

/ Enhanced Humans/ Medical

11. 18. 14 by StefanCretu

ZMapp, developed by Mapp Biopharmaceutical, was used in August to treat several patients in the ongoing Ebola virus outbreak
Five of the seven patients who received ZMapp survived
Now knowing how ZMapp targets Ebola, scientists can compare all newly discovered anti-Ebola antibodies and formulate a better immunotherapeutic drug

Share This Article

More on Enhanced Humans

Brain Transparency

Feb 3 on futurism

Duke Professor Welcomes the "Promising" Future of Employers Reading Your Brain

Brain-Computer Im...

Jan 3 on the byte

Neuralink Cofounder Says New Company's Eye Implant Could Be "Ultimate" VR Tech

Eyes Have It

12. 30. 22 on futurism

Meet the Neuralink Cofounder Who Left and Started a Competitor That's Now Rapidly Catching Up

Keep up.

Subscribe to our daily newsletter to keep in touch with the subjects shaping our future.

+Social +Newsletter

Topics About Us Contact Us

Copyright ©, Camden Media Inc All Rights Reserved. See our User Agreement, Privacy Policy and Data Use Policy. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission of Futurism. Articles may contain affiliate links which enable us to share in the revenue of any purchases made.